DEUTSCHE BANK AG\ - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 28 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q1 2021$29,000
+1350.0%
7,600
+1410.9%
0.00%
Q4 2019$2,000
-71.4%
503
-96.2%
0.00%
Q3 2019$7,0000.0%13,280
+188.6%
0.00%
Q2 2019$7,000
-53.3%
4,601
-44.9%
0.00%
Q1 2019$15,000
+650.0%
8,350
+542.3%
0.00%
Q4 2018$2,000
-98.4%
1,300
-95.9%
0.00%
Q3 2018$123,000
+324.1%
32,017
+491.0%
0.00%
Q2 2018$29,0005,4170.00%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q4 2019
NameSharesValueWeighting ↓
Anson Funds Management LP 5,302,036$11,558,4382.33%
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 201,453$449,2400.06%
BRAVE ASSET MANAGEMENT INC 25,000$54,9270.02%
Ausdal Financial Partners, Inc. 20,000$43,6000.01%
HEADINVEST, LLC 11,534$24,1060.01%
Cedar Mountain Advisors, LLC 5,651$12,3190.00%
Long Focus Capital Management, LLC 40,000$87,2000.00%
Banque Cantonale Vaudoise 11,900$260.00%
OSAIC HOLDINGS, INC. 9,712$21,1730.00%
DIMENSIONAL FUND ADVISORS LP 33,485$72,9970.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders